Takeda Unit Defends Bowel Disease Drug Patent In UK
A subsidiary of Japanese pharma giant Takeda has defended its U.K. patent for a bowel disease drug, urging a London court to uphold its protections as rival company Advanz vies to...To view the full article, register now.
Already a subscriber? Click here to view full article